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Prenatal Effects of Maternal Smoking
on Daughters' Smoking:
Nicotine or Testosterone Exposure?
Denise B. Kandel, PhD, and J. Richard Udry, PhD
We have found in 2 cohorts, even after
controlling for postnatal maternal smoking,
that female adolescents are more likely to
smoke if their mothers smoked during preg-
nancy.' We have found no such effect for male
offspring. In both samples, maternal smoking
in pregnancy was ascertained from maternal
self-reports subsequent to pregnancy. The
average recall periods were 3 years in one
cohort and less than 1 year in the other.
Effects of self-reported prenatal smoking on
smoking by 10-year-old offspring have also
been reported.2 Because of potential biases in
self-reports, a more direct test of the prenatal
smoking effect requires biological indicators
ofmaternal smoking during pregnancy.
Data are also needed on postnatal mater-
nal smoking to control for children's model-
ing oftheir mothers. The opportunity arose to
obtain such data in a longitudinal sample.
Although not assayed for cotinine, blood sera
were collected in pregnancy, and smoking
histories were subsequently obtained from
mothers and daughters during the daughters'
adolescence and from daughters in adult-
hood. Furthermore, the prenatal sera had been
assayed for testosterone, making it possible to
investigate the role of prenatal exposure to
testosterone in smoking by female offspring.
Kandel et al. hypothesized that one
mechanism underlying the effect of prenatal
smoking on offspring might be the impact of
nicotine or nicotine breakdown products on
the developing brain of the fetus.' Maternal
nicotine crosses the placental barrier, and
fetal cotinine levels reach about 90% of
maternal levels.3'4 Nicotine stimulates the
action of cholinergic neurons, increases nico-
tinic receptors in the brain,57 and enhances
activity in dopaminergic systems involved in
addictive behavior.>" Such findings raise the
possibility that during a critical prenatal
period of brain development, nicotine might
modify the dopaminergic system and change
the threshold of this system, or related sys-
tems in the brain, to the effects of nicotine
later in life. Fetal exposure to passive smok-
ing could also be relevant.
The Kandel et al. hypothesis has to be
evaluated in the context of findings from
behavior genetic studies that smoking is influ-
enced by genetic factors, 3 as well as the
possibility that prenatal exposure to com-
pounds other than nicotine also affects off-
spring smoking. Testosterone might be one
such factor. In male and female adolescents,
higher testosterone levels have been observed
among smokers than among nonsmokers.'4
Among adults, inconsistent associations
between testosterone and smoking have been
reported for men,15"6 while small-sample
studies show no relationship in (nonpreg-
nant) premenopausal women.'7"18 Smoking
appears to have an anti-estrogenic effect in
women.'9 Male sex hormones affect neu-
ronal brain structures and fumctions that con-
tribute to sex differences in behavior.20 Udry
et al.2' found that mothers' prenatal testos-
terone influenced daughters' later gendered
behavior.
Prenatal exposure may also lead to life-
long higher testosterone levels that may have
other consequences, such as higher novelty
and sensation seeking22'23 and stress sensitiv-
ity.24 In female fetuses, in contrast to male
fetuses, testosterone levels are determined by
maternal levels. Maternal testosterone may
affect the central nervous system of females
in utero and thus increase daughters' likeli-
hood of smoking. In addition, mothers' testos-
terone levels may be related to their own
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smoking and may affect daughters' smoking
indirectly. Adolescent testosterone has been
found to interact with maternal smoking in
predicting increasing rates of smoking by
female, but not male, adolescents.25
Thus, offspring smoking may be deter-
mined by prenatal exposure to cotinine, pre-
natal exposure to testosterone, or a genetic
predisposition. The genetic hypothesis could
not be tested with our data.
Methods
Data and Procedures
The sample included 471 White women
and their daughters (born in 1960-1963) from
the Child Health and Development Study.26
The women received prenatal care at the
Kaiser Foundation Health Plan clinic in the
California San Francisco Bay Area. During
pregnancy, maternal blood samples were taken
at each trimester; 1 sample was obtained from
fathers. Mothers and children were reinter-
viewed when the children were aged 9 to 11
and 15 to 17 years (n = 2020). Adolescent
daughters' interviews and prenatal sera were
available for 471 of 669 White mothers. In
1990-1991, Udry reinterviewed 351 daugh-
ters when they were aged 27 to 30 years
(74.5% completion rate) and obtained blood
samples from 240. Udry et al.2' assayed the
prenatal maternal sera and the adult daugh-
ters' sera for testosterone and sex hormone
binding globulin. On average, mothers were
aged 29 years at delivery and 45.4 years at the
initial adolescent interview; the mean age of
adolescents was 16.4 years.
Attrition from birth slightly biased the
adolescent sample through disproportionate
loss of daughters from families of low socio-
economic status.26 There were no significant
differences between adolescent offspring
reinterviewed in adulthood who provided
sera and those not reinterviewed (data not
presented).
In 1990, Udry obtained the prenatal
specimens from the National Cancer Institute
Frederick Cancer Research Facility in Fred-
erick, Md, and stored them at -20°C at the
University of North Carolina until the assay
was conducted. Numbers of specimens by
trimester were as follows: trimester 1, 453;
trimester 2, 377; and trimester 3, 391. In 1997,
the sera were assayed for cotinine, the major
metabolite of nicotine. Cotinine circulates in
the blood, and cotinine concentration is con-
sidered the best indicator of smoking.27-29
Other variables included concurrent
maternal reports of smoking in pregnancy,
self-reports of current smoking by moth-
ers and lifetime and current smoking by
daughters when the daughters were aged
15 to 17 years, daughters' current smoking at
ages 27 to 30 years, and maternal education
(less than eighth grade, 8-12 years or trade
school but not high school graduate, high
school graduate, high school graduate plus
additional training, some college, college
graduate). Daughters' lifetime smoking was
not ascertained in adulthood.
Quality ofCotinine Assays
Udry et al.21 documented that the means
and distributions of the testosterone and sex
hormone binding globulin assays conducted
in 1990-1991 were well within the previ-
ously published range for expected values at
each trimester. The cotinine assays were
conducted in 1997 by Dr Nancy Haley at the
laboratories of Metropolitan Life Insurance;
radioimmunoassay was used,30 modified by
the method of Langone et al.3' Sodium was
not controlled. All sera were assayed twice.
The detection limit was 2 ng/mL; the upper
limit was 480 ng/mL. The coefficient of vari-
ation was less than 2 ng/mL. Sera could not
be assayed for 5 women.
A major issue concerns the quality of
the assays performed on blood sera aged 34
to 37 years. Evidence from other studies,
consultation with experts on nicotine metab-
olism, evaluation ofthe samples by Dr Haley,
and results of the analysis indicate that the
assays were more than adequate to charac-
terize the smoking status of the pregnant
women in the sample. Among mothers who
smoked throughout their pregnancy, cotinine
values were slightly higher in trimester 2
(244 ng/mL) than in trimesters 1 and 3
(233 ng/mL and 218 ng/mL, respectively).
The mean cotinine value was 331 ng/mL
(SD = 154) for fathers with values above the
cutoff point recommended to identify active
smokers (i.e., 14 ng/mL or higher).2932
Nine percent ofmothers reported smok-
ing I to 4 cigarettes per day, 25% reported 5
to 9, 16% reported 10 to 14, 5% reported 15
to 19, 39% reported 20 to 29, 3.5% reported
30 to 39, and 3.5% reported 40 to 60. Dis-
crepancies between maternal self-reported
smoking and cotinine levels ranged from
4% in trimester 1 to 8% in trimesters 2 and
3 and were almost evenly divided between
(1) those who self-reported as smokers and
whose cotinine levels were below 14 ng/mL
and (2) those who self-reported as non-
smokers and whose cotinine levels were
above 14 ng/mL. The mean cotinine levels
of the self-acknowledged maternal smokers
were higher by about 50% than those
reported for sera collected from 1964 to
1967 Child Health and Development Study
cohorts.33
We attempted a comparison of cotinine
levels with levels reported by others for fresh
sera of smokers. Precise comparisons were
precluded owing to lack of detailed informa-
tion in most studies; noncomparability of
samples with regard to sex, pregnancy status,
age, and ethnicity; and lack of control for
trimester of pregnancy. The present values
were lower by about 10% than those
observed among Scottish women,34 similar to
those of a mixed sex and racial/ethnic sam-
ple,35 and higher than those of a sample of
pregnant women.36 While there probably is
some degradation of serum cotinine over
time, the levels among the Child Health and
Development Study smokers are well above
the 14-ng/mL cutoff value. Furthermore,
as discussed later, serum values are highly
related to self-reported number of cigarettes
smoked per day. Misclassification ofmothers
regarding their smoking status appears to be
very low.
StatisticalAnalyses
Nonsaturated causal models were esti-
mated via LISREL37 to assess the direct and
indirect paths linking the variables ofinterest:
the effects of fetal exposure to maternal
smoking and testosterone and of adolescent
exposure to maternal smoking on daughters'
smoking in adolescence and adulthood. Max-
imum-likelihood techniques were used in
estimating parameters of regression equa-
tions. Goodness of fit was assessed with a
standard nested x2 test. The goodness-of-fit
index was adjusted for degrees of freedom
relative to the number of variables. Values
greater than 0.90 are considered adequate.
A Wald test was used in testing regression
slopes (and paths) for significance.
LISREL has several advantages over
other methods: it can include a mixture of
types of correlations, it estimates correlated
errors, and it represents a full information
method in which all parameters and standard
errors are estimated simultaneously. Poly-
choric, polyserial, and Pearson correlations, as
appropriate, were entered by PRELIS in the
matrices. Two models were estimated, with
cotinine levels and maternal self-reported
smoking in pregnancy used as measures of
fetal nicotine exposure, for the 227 dyads in
which the daughters were reinterviewed in
adulthood and for whom there were complete
data on the relevant variables. Maternal educa-
tion was included in the models.
There is no experimental literature to
establish the period in pregnancy during
which the human fetal brain is most sensi-
tive to cotinine and testosterone. It has been
concluded, by extrapolation from animal
experiments, that sexual differentiation of
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TABLE 1-Correlations Between Trimester-Specific Prenatal Maternal Cotinine and Testosterone Levels: Child Health and
Development Study (n .327)
Trimester 1 Trimester 2 Trimester 3 Trimester 1 Trimester 2 Trimester 3
Cotinine Cotinine Cotinine Testosterone Testosterone Testosterone
Trimester 2 cotinine 0.85****
Trimester 3 cotinine 0.86**** 0.88***
Trimester 1 testosterone 0.11** 0.17**** 0.07
Trimester 2 testosterone 0.25**** 0.21**** 0.16*** 0.54****
Trimester 3 testosterone 0.08* 0.1 3** 0.12** 0.44**** 0.74****
*P<.10; **P<.05; ***P<.01; ****P< .001.
the human brain by testosterone starts in the portion (32.5%) reported smoking when their 14-ng/mL cutoffpoint used to identify smok-
early midtrimester of gestation.38 Because daughters were adolescents. Among daugh- ers. In trimester 2, maternal values were
of changes in fetal brain development in ters, 29.0% had smoked sometime in their 4.7 ng/mL when neither mothers nor fathers
trimester 2, analyses were based on trimester lifetime, and 15.4% were smoking when they smoked, 9.7 ng/mL when fathers smoked but
2 exposure. Trimester 1 cotinine and testos- were aged 15 to 17 years; 20.9% were smok- mothers did not, 209.5 ng/mL when mothers
terone values were substituted among the ing 12 years later. smoked and fathers did not, and 211.4 ng/mL
20% ofmothers for whom trimester 2 values when both smoked. Passive exposure to
were missing. Complete data were available Prenatal Maternal Smoking, Cotinine, fathers' smoking was not considered to be a
for 461 mother-adolescent dyads and 323 and Testosterone potential determinant ofoffspring smoking.
adult daughters, including 240 with testos- There was a significant relationship,
terone serum assays. There was a high association between especially in trimester 2, between maternal
maternal self-reported smoking in preg- cotinine and testosterone levels (Table 1).
nancy and serum cotinine levels in each Across the pregnancy, there was more sta-
Results trimester (r = 0.78-0.79). Cotinine values bility in cotinine than testosterone levels.
increased as a function of self-reported level There was no relationship between maternal
of smoking. In trimester 2, these values cotinine and sex hormone binding globulin
Prevalence ofSmokingAmong Mothers were 8 ng/mL for nonsmokers, 161.9 ng/mL in any trimester (data not shown).
and Daughters for mothers smoking fewer than 10 ciga-
rettes per day, 267.9 ng/mL for those smoking Maternal Prenatal Cotinine and
Ofthe mothers, 44.7% had cotinine lev- 1 pack per day, and 352 ng/mL for those Testosterone Levels and Daughters'
els above the cutoff point of 14 ng/mL or smoking 2 or more packs per day. Smoking
lower in at least 1 trimester; in trimester 2, Maternal serum cotinine values were
40.2%-the same percentage that reported little influenced by fathers' smoking. Mater- Three dichotomous measures of daugh-
smoking during their pregnancy-had levels nal self-reports of smoking were cross tabu- ters' smoking were examined as a function of
that exceeded the cutoff point. A lower pro- lated against fathers' cotinine levels, with the continuous measures of maternal prenatal
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TABLE 2-Correlations of Trimester 2 (T2) Maternal Prenatal Cotinine and Testosterone Levels With Self-Reported Prenatal
Smoking and Daughters' Smoking in Adolescence and Adulthood: Child Health and Development Study
Adolescent Adolescent Adult
Daughters' Daughters' Daughters'
T2 Maternal T2 Maternal Lifetime Current Current
Cotinine Testosterone Smoking Smoking Smoking
Mother
T2 testosteronea (n = 441) 0.15**
Self-reported prenatal smokingb (n = 441) 0.77** 0.12** 0.09 0.18** 0.33**
Daughter
Adolescent lifetime smokingb (n = 441) 0.04 0.14**
Adolescent current smokingb (n = 441) 0.13** 0.1 8** 0.68**c
Adult current smokingb (n = 325) 0.19** 0.12* 0.57** 0.59**
Adult testosteronea (n = 231) 0.02 0.16* -0.10 -0.03 0.23**
Note. PRELIS was used to estimate polychoric correlations between categorical variables and polyserial correlations between categorical and
continuous variables. Cases missing serum data in trimester 2 were assigned trimester 1 values.
aContinuous variable.
bCategorical variable: mother, 3 categories (did not smoke, smoked fewer than 15 cigarettes per day, smoked 15 or more cigarettes per day);
daughter, 2 categories (did not smoke, smoked).
cPearson r; iteration of polychoric correlation did not converge because of zero value in the never-smoked cell.
*P<.05; **P<.01.
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cotinine and testosterone levels: lifetime and
current smoking at 15 to 17 years of age and
smoking at 27 to 30 years of age (Table 2).
Statistically significant zero-order associa-
tions were observed between each prenatal
biological measure and the measures of
daughters' smoking with the exception of
lifetime smoking in adolescence, which was
unrelated to cotinine levels. Adult daughters'
testosterone levels were related to maternal
prenatal testosterone and daughters' current
smoking.
Predictors ofSmoking by Daughters in
Adolescence andAdulthood
Nonsaturated causal models were esti-
mated to identify the direct and indirect
effects of fetal exposure to maternal nicotine
and testosterone on daughters' smoking in
adolescence and adulthood. We assumed that
maternal nicotine and testosterone directly
affected daughters' smoking in adolescence
but had only indirect effects on their smoking
in adulthood (through maternal smoking and
daughters' smoking in adolescence). A 3-
category measure of maternal smoking when
the daughter was an adolescent was entered
to control for the modeling effect of mothers
by daughters.
Adult daughters' testosterone was
assumed to be affected by prenatal expo-
sure to maternal testosterone and to be cor-
related with their adult smoking. One model
included cotinine levels as a measure of pre-
natal nicotine exposure (Figure 1); another
included mothers' self-reported smoking dur-
ing their pregnancy (Figure 2). The models
were reestimated to include a correlated error
suggested by modification indexes. For sim-
plification, the paths from maternal educa-
tion and the correlated errors other than that
between adult daughters' current smoking
and testosterone are not shown.
Exposure to prenatal maternal cotinine
had no direct effect on daughters' smoking
(Figure 1). Prenatal maternal testosterone had
a direct effect on daughters' smoking in ado-
lescence, an indirect effect on daughters'
smoking in adulthood (through its effects on
adolescent smoking), and a direct effect on
adult daughters' testosterone. There was a
highly significant path from prenatal mater-
nal cotinine level to maternal smoking during
the daughters' adolescence, which was a sig-
nificant predictor of the daughters' smoking
in adolescence and adulthood. The strongest
predictor of an adult daughter's current
smoking was her smoking in adolescence.
For daughters, as for mothers, there was
strong continuity of smoking over time.
Maternal prenatal cotinine and testos-
terone were positively correlated. Similarly,
there was a significant correlation (P<.01)
between adult daughters' smoking and testos-
terone. There was a significant negative
effect of maternal education on daughters'
smoking in adolescence (standardized path
coefficient=-0.276, P<.001) but no effect
on mothers' own smoking during their
daughters' adolescence over and beyond the
correlation between smoking and education
observed in pregnancy. Including a correla-
tion between the error terms for mothers'
smoking during daughters' adolescence and
daughters' smoking in adulthood improved
the fit ofthe model (data not shown).
In contrast to prenatal cotinine, mater-
nal self-reported prenatal smoking had a sig-
nificant direct positive effect on daughters'
smoking in adolescence (Figure 2). In addi-
tion, maternal smoking during daughters'
adolescence no longer had an effect on daugh-
ters' smoking in adolescence. Surprisingly,





0.186X (0.063) = 10.83 (df-6);P 0.094
AGFI =0.939
Note. Mothers education is controlled for but not shown. Coefficients are standardized; standard errors are shown in parentheses.
Correlated errors between mother's smoking and adult daughter's smoking are estimated but not shown. AGFI =adjusted goodness-
of-fit index.
*P<.05; **P<.01; ***P<.001.
FIGURE 1 -Predictors of daughters' smoking in adolescence and adulthood (n=227): model including maternal cotinine
levels in pregnancy.
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the time-lagged effect of maternal smoking
on daughters' smoking in adulthood was
stronger than the contemporaneous effect
in adolescence. The effects ofprenatal testos-
terone on daughters' smoking in adolescence
and on testosterone levels in adulthood
remained unchanged. However, the path from
prenatal maternal testosterone to maternal
smoking during the daughters' adolescence
became significant.
Discussion
This study replicated previous findings of
an association between self-reported prenatal
maternal smoking and smoking by adolescent
daughters.' However, the hypothesis that fetal
exposure to maternal cotinine during preg-
nancy increases the liability offemale offspring
to smoking was not confirmed with biological
assays of cotinine concentration in prenatal
sera. (Despite the length of time that elapsed
from collection to assays of the sera, the evi-
dence suggests that the quality of the samples
was good.) Prenatal exposure to maternal
testosterone emerged as a significant predictor
ofdaughters' smoking in adolescence and their
testosterone levels in adulthood. Among both
mothers and daughters, testosterone was signif-
icantly correlated with smoking. Maternal
smoking during the daughters' adolescence
was a consistently strong predictor of daugh-
ters' smoking in adolescence and adulthood.
Daughters' adult smoking was also predicted
by their adolescent smoking.
Results regarding the effect of prenatal
maternal smoking on offspring smoking
appear to depend on the measure of maternal
smoking. We speculate that the seemingly
stronger effect of self-reported smoking than
of cotinine serum levels may result in part
from a lack of exact correspondence between
cotinine levels in sera and in the brain. Fur-
thermore, nicotine metabolites other than
cotinine may contribute to the differential
associations of cotinine levels and self-
reported smoking. Most studies of the behav-
ioral consequences of fetal exposure to
maternal smoking are based on maternal self-
reports39'40 and may exaggerate the effects of
prenatal cotinine exposure.
The present findings also suggest that the
risk factor indexed by maternal smoking in
pregnancy may not be cotinine but testos-
terone in mothers and offspring. The mecha-
nisms underlying the relationships of prenatal
testosterone with mothers' and daughters'
smoking remain to be elucidated. Nicotine and
cotinine have been reported (with an excep-
tion41) to affect hormone synthesis and metab-
olism and to decrease testosterone levels in
animals.42A5 Thus, the relationship between
testosterone and nicotine is somewhat para-
doxical. Studies ofgeneral population samples
show, as found here, that at any particular
point in time smokers tend to have higher
testosterone levels than nonsmokers.'4'25'45
However, inconsistent findings have been
reported in studies based on clinical or
selected samples.46 Whether intrauterine fetal
exposure to nicotine has any effect on off-
spring through testosterone in the mother and
child remains to be determined for both
female and male offspring.
The persistence of the effect of maternal
smoking during daughters' adolescence on
daughters' smoking in adulthood (after control
for adolescent daughters' smoking) and its
stronger effect on daughters' smoking in adult-
hood than in adolescence (when prenatal
smoking was indexed by maternal self-
reports) were unexpected. We would expect
the maternal role modeling effect to be
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stronger contemporaneously than 12 years
later, especially when adolescents reside with
their parents and initiation into smoking takes
place. Maternal smoking during daughters'
adolescence may index genetic and socializa-
tion effects. However, our data do not allow us
to examine to what extent and by what mecha-
nism mother-to-child transmission of smoking
is genetically mediated.
This study has shown a novel association
between fetal prenatal exposure to maternal
testosterone and subsequent smoking by ado-
lescent female offspring. Data based on bio-
logical assays of prenatal cotinine do not pro-
vide support for the initial hypothesis, based
on self-reports of smoking, that exposure to
intrauterine maternal nicotine directly
increases the risk of smoking among female
offspring. Correspondence between cotinine
levels in blood and in the brain needs to be bet-
ter established, and the effects of nicotine or
cotmiine on testosterone and the role of smoke
compounds and nicotine metabolites other
than cotinine need to be better understood,
before the hypothesis of an effect of exposure
to prenatal maternal nicotine on offspring
smoking is discarded. D
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